United States===United States Food and Drug Administration
Tracked across 4 events · 523 articles · First seen Jan 29, 2026 · Last active Apr 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
The United States===United States Food and Drug Administration issued a Complete Response Letter for Corcept Therapeutics' drug candidate, relacorilant, due to insufficient evidence of effectiveness. This action directly led to the significant drop in Corcept Therapeutics' stock price.
Jan 29, 2026 · 252 articles
Regulatory
The United States===United States Food and Drug Administration issued a warning letter to ImmunityBio, stating that the company's promotional materials for Anktiva were false or misleading. This action by the United States===United States Food and Drug Administration directly led to the securities class action lawsuit and the drop in ImmunityBio's stock price.
Jan 29, 2026 · 188 articles
Business
The United States===United States Food and Drug Administration issued a Complete Response Letter for Aldeyra Therapeutics's drug candidate reproxalap, citing a lack of substantial evidence for efficacy.
Mar 20, 2026 · 76 articles
Business
The U.S. FDA is mentioned as a regulatory body whose standards the new Syntex™ gloves comply with, indicating the product's adherence to important safety and quality benchmarks for the United States market.
Apr 03, 2026 · 7 articles
Intco Medical
complies with
↔
United States===United States Food and Drug Administration
Intco Medical's Syntex™ gloves comply with U.S. FDA standards for medical gloves
NEWSDESK
Track United States===United States Food and Drug Administration live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard